|
|
|
Company Name
|
Talon Therapeutics, Inc.
|
|
Drug Name
|
Marqibo (NDA)
|
|
Event Name
|
FDA decision on Marqibo in the proposed treatment of adult Philadelphia chromosome-negative acute lymphoblastic leukemia
|
|
Event Date
|
05/13/2012
|
|
Outcome
|
FDA postpones decision on Marqibo by 3 months to August 12
|
|
Drug Status
|
|
|
Rival Drugs
|
|
|
Market Potential
|
|
|
Other Approvals
|
|
|
News |
|
|
|
Return to FDA Calendar
|